The specification for the Pharmacy Contraceptive Service is now available for pharmacy contractors to download from the NHSBSA website. The specification includes the training requirements for the service. The service will not start on 11th January 2023, as originally planned, but it is expected to commence in early 2023. The exact start date is yet [...]
The post Contraception service spec published appeared first on PSNC Website.
The Royal Pharmaceutical Society (RPS) has published a ten-year vision for the future of pharmacy professional practice in England. The vision, which was co-produced by The King’s Fund, explores how pharmacy teams in all care settings can support improved care for patients and help to address the many health challenges facing the country. It calls for [...]
The post RPS publishes Vision for Pharmacy Professional Practice in England appeared first on PSNC Website.
In response to significant ongoing disruption affecting supply of Phenoxymethylpenicillin oral solution, the Department of Health and Social Care (DHSC) has issued three new Serious Shortage Protocols (SSPs). The SSPs, introduced with immediate effect, allow community pharmacists to consider different options to enable continued supply of Phenoxymethylpenicillin to mitigate the ongoing supply disruptions affecting this [...]
The post Three SSPs issued for Phenoxymethylpenicillin (Pen V) oral solution appeared first on PSNC Website.
Following on from our update about antibiotic supply and pricing issues on Friday 9th December, we wanted to share some recent developments. HDA statement The Healthcare Distribution Association (HDA), whose member companies distribute over 90% of prescription medicines on behalf of the NHS, has issued a lengthy statement regarding the availability of Strep A treatments. [...]
The post Antibiotic supply and pricing issues: Steps taken this week appeared first on PSNC Website.
Update (30/01/2023) – Following representations from PSNC, the Department of Health of Social Care (DHSC) has re-determined the special container status of all Co-beneldopa capsules and tablets. In December 2022, PSNC advised that the special container rules apply to all branded or generically written prescriptions for Madopar® dispensed from December 2022 onwards (except for generically prescribed Co-beneldopa 12.5mg/50mg [...]
The post Co-beneldopa (including Madopar®) preparations re-classified as special containers appeared first on PSNC Website.
Recent Comments